Crossover of Aimovig with NDC 55513-843 a human prescription drug with other products matching the same product name (Aimovig) or generic name (Erenumab-aooe), and the same administration route (subcutaneous) or dosage form (injection, solution).
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 55513-840 | Aimovig | Erenumab-aooe | Injection | Subcutaneous | Amgen Inc | Human Prescription Drug |
| 55513-841 | Aimovig | Erenumab-aooe | Injection | Subcutaneous | Amgen Inc | Human Prescription Drug |
| 55513-842 | Aimovig | Erenumab-aooe | Injection, Solution | Subcutaneous | Amgen Inc | Human Prescription Drug |